Alendronate: which country? [Design Issues]

posted by jchapdelaine – 2010-05-13 00:16 (5884 d 09:26 ago) – Posting: # 5336
Views: 4,093

Regarding the use of plasma or urine, originally it was not possible to analyze the plasma levels due to sensivitiy issues for bisphosphonates. However labs now have the sensitivity to analyze plasma PK profiles. Last year I discussed with FDA why for alendronate it is recommended to analyze in urine when plasma is available. The response was that it is an old recommendation, and that if plasma PK analysis is possible, then this should be used.
My lab currently has a method for both plasma and urine analysis, however as of now, sponsors have only used the urine method.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
137 visitors (0 registered, 137 guests [including 28 identified bots]).
Forum time: 09:43 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5